2.04 USD
▲-0.15+2.00%
盘后 2.04 +2.11%
2026-08-03
市值
$151.44M
市盈率
—
EPS
-0.06
股息率
—
52 周区间
1.43 – 67.00
成交量
54.29K
Beta
—
目标价
—
52W 低 1.4352W 高 67.00
价格走势
公司简介
Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.